Since it had been found that some breast and ovarian cancer susceptibility alleles, e.g. in BRCA2 (the FANCD1 gene), PALB2 (the FANCN gene) or RAD51C (the FANCO gene), cause Fanconi Anemia (FA) in the homozygous state, it has been reasonable to assess further FA genes for their role in breast and ovarian cancer. This evidence concerns the gene RAD51C and ovarian carcinoma.